Beximco Pharmaceuticals Limited (AIM: BXP)

Beximco Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	1,160	1,136	1,169	675.47	635.02	610.49
Short-Term Investments	571.13	166.25	108.07	112.83	70.79	381.53
Cash & Short-Term Investments	1,732	1,302	1,277	788.3	705.81	992.03
Cash Growth	31.78%	1.97%	61.96%	11.69%	-28.85%	23.62%
Accounts Receivable	3,759	3,370	2,963	2,726	3,089	3,245
Other Receivables	-	215.62	217.35	174.05	223.58	96.58
Receivables	3,759	3,586	3,180	2,900	3,312	3,341
Inventory	13,532	13,473	11,573	8,265	7,163	7,242
Prepaid Expenses	-	60.96	53.23	36.03	155.35	163.84
Other Current Assets	2,791	2,455	2,335	1,781	1,713	1,525
Total Current Assets	21,814	20,876	18,419	13,771	13,049	13,264
Property, Plant & Equipment	42,904	42,808	42,212	36,531	35,241	34,057
Long-Term Investments	20.97	20.97	23.36	16.59	3.75	5.33
Goodwill	674.57	674.57	674.57	546.69	546.69	546.69
Other Intangible Assets	4,749	4,721	4,730	1,381	1,276	1,335
Long-Term Deferred Tax Assets	61.18	56.51	88.64	-	-	-
Total Assets	70,223	69,157	66,148	52,246	50,119	49,214
Accounts Payable	-	1,618	1,373	769.2	575.01	573.35
Accrued Expenses	1,042	2,581	2,042	1,420	1,466	994.04
Short-Term Debt	4,270	6,621	6,851	5,023	7,398	9,273
Current Portion of Long-Term Debt	1,406	1,293	1,905	1,287	1,346	1,451
Current Portion of Leases	148.73	146.52	160.58	113.98	108.12	165.77
Current Income Taxes Payable	620.78	454.09	99.45	222.51	285.89	167.3
Current Unearned Revenue	-	149.41	110.41	298.4	12.39	23.95
Other Current Liabilities	4,655	401.5	193.85	214.81	165.61	98.02
Total Current Liabilities	12,142	13,265	12,736	9,350	11,358	12,746
Long-Term Debt	1,271	2,158	2,997	972.7	1,443	2,348
Long-Term Leases	333.29	393.12	456.76	234.02	208.86	247.38
Long-Term Deferred Tax Liabilities	2,503	2,550	2,537	1,990	2,168	2,147
Other Long-Term Liabilities	-	1,295	1,161	1,013	958.38	820.88
Total Liabilities	19,813	21,537	21,512	14,881	17,321	19,350
Common Stock	4,461	4,461	4,461	4,461	4,056	4,056
Additional Paid-In Capital	6,959	6,959	6,959	6,959	6,959	6,959
Retained Earnings	33,599	30,806	27,748	24,180	20,059	17,144
Comprensive Income & Other	1,451	1,454	1,432	1,431	1,422	1,429
Total Common Equity	46,471	43,681	40,600	37,031	32,495	29,588
Minority Interest	3,940	3,939	4,036	334.31	302.33	276.01
Shareholders' Equity	50,411	47,620	44,636	37,365	32,797	29,864
Total Liabilities & Equity	70,223	69,157	66,148	52,246	50,119	49,214
Total Debt	7,428	10,612	12,371	7,631	10,504	13,485
Net Cash (Debt)	-5,696	-9,310	-11,094	-6,843	-9,798	-12,493
Net Cash Per Share	-12.77	-20.87	-24.87	-15.34	-21.96	-28.00
Filing Date Shares Outstanding	446.11	446.11	446.11	446.11	446.11	446.11
Total Common Shares Outstanding	446.11	446.11	446.11	446.11	446.11	446.11
Working Capital	9,672	7,611	5,683	4,421	1,691	518.33
Book Value Per Share	104.17	97.91	91.01	83.01	72.84	66.32
Tangible Book Value	41,048	38,285	35,196	35,103	30,673	27,707
Tangible Book Value Per Share	92.01	85.82	78.90	78.69	68.76	62.11
Land	7,893	7,892	-	4,068	4,068	4,068
Buildings	16,794	16,690	-	8,129	7,822	7,820
Machinery	31,925	31,747	-	18,663	17,542	17,500
Construction In Progress	2,783	1,847	-	16,507	15,789	13,753

Source: S&P Capital IQ. Standard template. Financial Sources.